For GLP-1 users, the in-store clothes shopping trip is back
Danielle Kaye
Reuters
Updated
CBC English
"If everybody's on Ozempic, there won't be enough humans in the world to alter those dresses." This bridal shop owner has already seen how Ozempic and GLP-1 drugs can dramatically 'alter' wedding dresses. Watch The Ozempic Effect: Beyond the Waistline on CBC Gem.
NEW YORK — Nora Nye, 58, is refreshing her wardrobe as she sizes down for the first time in over three decades after losing 80 pounds on weight-loss drug Mounjaro. Earlier this year, the Denver bankruptcy lawyer walked into a Macy's and found herself overwhelmed.
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
A new analysis is raising safety concerns about Wegovy, the blockbuster GLP-1 weight-loss drug, after researchers found it may carry the highest risk among similar medications of a rare condition called nonarteritic anterior ischemic optic neuropathy — sometimes called an "eye stroke" — that can cause sudden, permanent vision loss. The finding adds to a growing list of questions surrounding long-term GLP-1 safety even as millions of Americans use these drugs for weight loss and diabetes. Researchers say patients experiencing sudden vision changes should seek emergency care immediately. Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools. WooGlobe Ref : WGA126542
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
Nora Nye poses for a portrait in a new outfit she purchased after losing weight while on the GLP-1 medication Mounjaro, July 27 at her home in Denver, Colo.
